Displaying publications 81 - 100 of 151 in total

Abstract:
Sort:
  1. Cigarette price level and variation in five Southeast Asian countries
    Liber AC, Ross H, Ratanachena S, Dorotheo EU, Foong K
    Tob Control, 2015 Jun;24(e2):e137-41.
    PMID: 24500266 DOI: 10.1136/tobaccocontrol-2013-051184
    OBJECTIVES: To monitor and analyse impacts of the interaction between tobacco excise tax policy and industry price strategy, on the price level and variation of cigarettes sold in five Southeast Asian countries (Indonesia, Cambodia, Lao PDR, the Philippines and Vietnam).
    METHODS: Prices of cigarette sold by sticks and packs were collected through an in-person survey of retailers during 2011. Mean cigarette prices and price variation were calculated in each study country for single cigarettes, whole packs and brand groups.
    RESULTS: Price variation of whole packs was greater in countries with ad-valorem excise tax structures (Cambodia, Lao PDR and Vietnam) than in countries with multitiered specific excise taxes (Indonesia and the Philippines). The price variation for single sticks appeared to be driven by local currency denomination. Cigarettes sold individually cost more per stick than cigarettes sold in whole packs in every brand group except for Indonesia's domestic brands.
    CONCLUSIONS: Tobacco industry strategy and excise tax structure drove the price level and variation of cigarettes sold in packs, while currency denominations influence the selling price of single sticks. To maximise the effectiveness of tobacco tax policies, countries should adopt specific excise tax structures to decrease cigarette price variation, which would minimise opportunities for smokers to 'trade down' to a cheaper brand to avoid a tax-driven price increase.
    KEYWORDS: Low/Middle Income Country; Packaging and Labelling; Price; Surveillance and Monitoring; Taxation
    Matched MeSH terms: Costs and Cost Analysis*
  2. Fulltext An empirical study on asymmetric jump diffusion for option and annuity pricing
    Lau KJ, Goh YK, Lai AC
    PLoS One, 2019;14(5):e0216529.
    PMID: 31063498 DOI: 10.1371/journal.pone.0216529
    In this paper, we present a method to estimate the market parameters modelled by an asymmetric jump diffusion process. The method proposed is based on Kou's jump diffusion model while the market parameters refer to the market drift, the market volatility, the jump intensity on market price, and the rate of jump occurrence in a consistent manner throughout the entire paper. The model captures the asymmetric nature of the price fluctuation during up trend markets and down trend markets. The results are compared to conventional options to observe the impact of jump effects. The results from simulation show that the asymmetric jump diffusion model can estimate the fair prices of European call options and annuity better than the Black-Scholes model and the symmetric jump diffusion model proposed by Kou and Merton.
    Matched MeSH terms: Costs and Cost Analysis*
  3. Fulltext A malaria-control experiment in the interior of Borneo
    De Zulueta J, Lachance F
    Bull World Health Organ, 1956;15(3-5):673-93.
    PMID: 13404443
    A first experiment on malaria control in the interior of Borneo by spraying with residual insecticides is described. The work was carried out in the isolated, sparsely populated valleys of the Baram River and its tributary, the Tinjar, in northern Sarawak. The experimental area was divided into three parts: a DDT test area, where a 75% suspension of wettable powder was applied at the rate of 2 g of DDT per m(2) of surface; a BHC test area, where a 50% suspension of wettable powder was applied at the rate of 0.10 g of gamma isomer per m(2); and a check area.Entomological investigations made before the spraying operations were started showed that Anopheles leucosphyrus Dönitz, 1901 was the main malaria vector in both the test and the check areas. Out of a total of 7568 A. leucosphyrus dissected, 30 gland infections were detected-a sporozoite-rate of 0.40%. A. barbirostris was found to be a secondary vector throughout the experimental area.THE RESULTS OF INSECTICIDE SPRAYING WERE SATISFACTORY: in the DDT test area, the spleen-rate fell from 51.8% to 25.1%, and the parasite-rate from 35.6% to 1.6%, in 21 months, and a similar reduction in the rates was observed in the BHC test area. In the check area, the spleen- and parasite-rates rose during the period of observations. It is considered that if such a degree of control can be obtained in 21 months, complete eradication can be expected in the near future.Although BHC spraying proved effective, the fact that it has to be repeated every three months makes it impracticable in the interior of Sarawak, where communications are very poor and difficulties of transport very great. DDT spraying, which need only be done twice a year, is therefore to be preferred. The cost of the DDT operations-US$ 0.45 per person protected per year-is comparatively high, owing to the difficulty of communications and to the necessity for spraying not only the village "longhouses", but also the temporary shelters which the semi-nomadic people in the interior of Sarawak build each year in the rice-fields.
    Matched MeSH terms: Costs and Cost Analysis*
  4. Fulltext Cost analysis of private primary care services hn three urban centres in Malaysia
    Syed Mohamed Aljunid, Nyunt-U, Soe, Cheah, Molly, Kwa, S.K., Rohaizat Yon, Ding, L.M.
    Malaysian Journal of Public Health Medicine, 2001;1(1):8-15.
    MyJurnal
    A study was undertaken amongst private primary care providers in three urban centres of Malaysia to understand the organizational structure of the facilities and to assess the cost of running such services. A total of 150 clinics were involved in the study. Data was collected through interviews with owners of the clinics using semi-structured questionnaires. Solo-practitioners owned 64.7% of the clinics while 35.3% of them were owned by group practice. This study showed that the mean number of patients visited the clinics daily was 49.3 with the average operating hours of 79.4 hours/week (range 28.0 - 168.0 hours/week). Group practice clinics operates 23.9 hours longer than solo-practice clinics. Group practice clinics were more likely to offer 24 hours service than solo-practice clinics. Most of the clinics were manned by a single doctor (57.3%), 30.0 % had two doctors and only 12.7% were run by more than two doctors. On average, group practice employed greater number of supporting staff than solo-practice clinics (6.0 vs 4.3 people). The mean annual cost to run each facility was found to be RM 444,698. The mean cost per patient was found to be RM 32.09 for solo-practice clinics and RM 38.55 for group practice. Wages represented the highest proportion in the recurrent cost (61.1%) followed by drugs (29.2%) and consumables (2.7%). Building cost (67.9%) and equipment cost (25.9%) were the major capital costs for the clinics. This study could serve as a basis to reimburse private primary care providers in the future health financing scheme in Malaysia. To improve efficiency and contain cost in primary care settings, efforts should be targeted towards cost of wages and drugs utilised by the providers in their daily practice.
    Key words: Private practice; primary care; costs; Malaysia.
    Matched MeSH terms: Costs and Cost Analysis*
  5. Fulltext Approaches to refining estimates of global burden and economics of dengue
    Shepard DS, Undurraga EA, Betancourt-Cravioto M, Guzmán MG, Halstead SB, Harris E, et al.
    PLoS Negl Trop Dis, 2014 Nov;8(11):e3306.
    PMID: 25412506 DOI: 10.1371/journal.pntd.0003306
    Dengue presents a formidable and growing global economic and disease burden, with around half the world's population estimated to be at risk of infection. There is wide variation and substantial uncertainty in current estimates of dengue disease burden and, consequently, on economic burden estimates. Dengue disease varies across time, geography and persons affected. Variations in the transmission of four different viruses and interactions among vector density and host's immune status, age, pre-existing medical conditions, all contribute to the disease's complexity. This systematic review aims to identify and examine estimates of dengue disease burden and costs, discuss major sources of uncertainty, and suggest next steps to improve estimates. Economic analysis of dengue is mainly concerned with costs of illness, particularly in estimating total episodes of symptomatic dengue. However, national dengue disease reporting systems show a great diversity in design and implementation, hindering accurate global estimates of dengue episodes and country comparisons. A combination of immediate, short-, and long-term strategies could substantially improve estimates of disease and, consequently, of economic burden of dengue. Suggestions for immediate implementation include refining analysis of currently available data to adjust reported episodes and expanding data collection in empirical studies, such as documenting the number of ambulatory visits before and after hospitalization and including breakdowns by age. Short-term recommendations include merging multiple data sources, such as cohort and surveillance data to evaluate the accuracy of reporting rates (by health sector, treatment, severity, etc.), and using covariates to extrapolate dengue incidence to locations with no or limited reporting. Long-term efforts aim at strengthening capacity to document dengue transmission using serological methods to systematically analyze and relate to epidemiologic data. As promising tools for diagnosis, vaccination, vector control, and treatment are being developed, these recommended steps should improve objective, systematic measures of dengue burden to strengthen health policy decisions.
    Matched MeSH terms: Costs and Cost Analysis/methods
  6. Fulltext Rapid Assessment of Price Instability and Paucity of Medicines and Protection for COVID-19 Across Asia: Findings and Public Health Implications for the Future
    Godman B, Haque M, Islam S, Iqbal S, Urmi UL, Kamal ZM, et al.
    Front Public Health, 2020;8:585832.
    PMID: 33381485 DOI: 10.3389/fpubh.2020.585832
    Background: Countries have introduced a variety of measures to prevent and treat COVID-19 with medicines and personal protective equipment (PPE), with some countries adopting preventative strategies earlier than others. However, there has been considerable controversy surrounding some treatments. This includes hydroxychloroquine where the initial hype and misinformation lead to shortages, price rises and suicides. Price rises and shortages have also been seen for PPE. Such activities can have catastrophic effects on patients where there are high co-payment levels and issues of affordability. Consequently, there is a need to investigate this further. Objective: Assess changes in the availability, utilization and prices of relevant medicines and PPE during the pandemic among a range of Asian countries. Our approach: Narrative literature review combined with interviews among community pharmacists to assess changes in consumption, prices and shortages of medicines and PPE from the beginning of March 2020 until end of May 2020. In addition, suggestions on ways to reduce misinformation. Results: 308 pharmacists took part from five Asian countries. There was an appreciable increase in the utilization of antimicrobials in Pakistan (in over 88% of pharmacies), with lower increases or no change in Bangladesh, India, Malaysia and Vietnam. Encouragingly, there was increased use of vitamins/immune boosters and PPE across the countries, as well as limited price rises for antimicrobials in India, Malaysia and Vietnam, although greater price rises seen for analgesics and vitamin C/immune boosters. Appreciable price increases were also seen for PPE across some countries. Conclusion: Encouraging to see increases in utilization of vitamins/immune boosters and PPE. However, increases in the utilization and prices of antimicrobials is a concern that needs addressing alongside misinformation and any unintended consequences from the pandemic. Community pharmacists can play a key role in providing evidence-based advice, helping to moderate prices, as well as helping address some of the unintended consequences of the pandemic.
    Matched MeSH terms: Costs and Cost Analysis*
  7. Fulltext Pharmacoeconomic evaluation and burden of illness of acute exacerbation of COPD in patients in Malaysia. [Abstract]
    Iqbal MS, Iqbal MZ, Barua A, Veettil SK, Wei LY, Kit LW, et al.
    Value Health, 2014 Nov;17(7):A594.
    PMID: 27202037 DOI: 10.1016/j.jval.2014.08.2046
    OBJECTIVES. Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) appears to be the main reason of hospitalization in COPD patients. Since substantial economic burden of COPD have not been previously studied in Malaysia, this study aimed at estimating and identifying different costs and related burden of illness in patients receiving treatment of AECOPD in a tertiary care hospital in Malaysia.
    METHODS. A prospective follow-up study was performed in Department of Accident and Emergency and Respiratory Medicine of the hospital. Data were derived on the basis of per exacerbation episode. Relationship between direct medical costs and disease severity was analyzed using various descriptive and inferential statistical approaches.
    RESULTS. Median actual direct medical costs and out-of-pocket costs were RM 457.68 (US$ 141.97) and RM 28.25 (US$ 8.76) per exacerbation respectively. Drug cost (41%) was the leading cost driver, followed by unit cost of treatment per bed (33.6%) and lab investigation cost (25.4%). However, food cost (44.2%) represented the largest proportion in out-of-pocket costs. More than 90% of actual direct medical costs were supported by the Government of Malaysia in the patients studied.
    CONCLUSIONS. Impacts of AECOPD in health care resources are worthy of attention. Cost information from pharmacoeconomic studies is important in decision making for health care professionals and policy makers in order to improve health care outcome and minimize costs.
    Matched MeSH terms: Costs and Cost Analysis
  8. A prospective prescription cost analysis of asthma medication. [Abstract]
    Khan AH, Aftab RA, Sulaiman SA, Ali I
    Value Health, 2015 Nov;18(7):A840.
    PMID: 26534490 DOI: 10.1016/j.jval.2015.09.373
    Objectives: To review patient’s prescriptions and calculate direct cost for the treatment and management of asthma
    Methods: A prospective cross-sectional detailed review of 180 prescriptions written by 6 doctors was conducted at respiratory department of Hospital Pulau Pinang, Malaysia. Medication price was confirmed from the hospital formulary. Interview with the key personals were conducted to identify activities of each service provided to asthma patients. This was followed by determination of time taken to complete each activity using stopwatch. The duration was captured 15 times for each for three alternate days and summarized as the mean time (minutes) for each activity. The cost of each employee per single activity was obtained by multiplying the mean time (minute) spent by that employee doing a specific activity by his/her salary per minute
    Results: A total of 6 different classes of medications were prescribed to 180 asthma patients. β agonist was the most prescribed class of asthma medication that included Salbutamol 72 (39.8) and albuterol 20 (11) followed by Corticosteroids that included budisonide 59 (32.8%), prednisolone 16 (8.8%) and fluticasone 11 (6.1%). Fifty one (28.3%) units of budisonide/formoterol combination medication were prescribed followed by fluticasone/salmeterol 40 (22.2%). A total of RM 10610.79(USD) medication were prescribed to 180 asthma patients with average cost of RM 59.08 per patient. The combination medication of budisonide/formoterol RM.5253 (USD) made the majority of total cost of asthma medication. Spirometry was performed for all 180 patients at every hospital visit that costed RM 5400.00. The cost of services provided by doctors and nursing staff for 180 asthma patients for single visit was RM 1198.8 and RM 331.2 respectively
    Conclusions: Combination medication adds a substantial cost to over all asthma cost. Careful selection of asthma pharmacotherapy can greatly reduce medication cost without compromising on treatment outcomes
    Matched MeSH terms: Costs and Cost Analysis
  9. Fulltext Expanding access to high-cost medicines through the E2 access program in Thailand: effects on utilisation, health outcomes and cost using an interrupted time-series analysis
    Sruamsiri R, Wagner AK, Ross-Degnan D, Lu CY, Dhippayom T, Ngorsuraches S, et al.
    BMJ Open, 2016;6(3):e008671.
    PMID: 26988346 DOI: 10.1136/bmjopen-2015-008671
    In 2008, the Thai government introduced the 'high-cost medicines E2 access program' as a part of the National List of Essential Medicines to increase patient access to medicines, improve clinical outcomes and make medicines more affordable. Our objective was to examine whether the 'high-cost medicines E2 access program' achieved its goals.
    Matched MeSH terms: Costs and Cost Analysis
  10. Fulltext Assessing the burden of pneumonia using administrative data from Malaysia, Indonesia, and the Philippines
    Azmi S, Aljunid SM, Maimaiti N, Ali AA, Muhammad Nur A, De Rosas-Valera M, et al.
    Int J Infect Dis, 2016 May 24;49:87-93.
    PMID: 27235085 DOI: 10.1016/j.ijid.2016.05.021
    To describe the incidence, mortality, cost, and length of stay (LOS) of hospitalized community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP) in three Southeast Asian countries: Malaysia, Indonesia, and the Philippines.
    Matched MeSH terms: Costs and Cost Analysis
  11. Fulltext Dataset on the dynamic structural parameters of an old existing building exposed to earthquake loading before and after strengthening techniques - A case study, Lebanon
    Kassem MM, Mohamed Nazri F
    Data Brief, 2018 Dec;21:2262-2283.
    PMID: 30555866 DOI: 10.1016/j.dib.2018.11.077
    This paper provides data and information on Beirut Arab University׳s existing old building in Lebanon. The building was primarily designed to resist gravity loads only, with no attention to seismic or lateral load effects. The data shows that there is a need to improve the conditions of the existing old building by applying new features that function as seismic capacity resistance. The first feature was applied by adding RC-shear walls to the existing building, and the second feature was by implementing concentric steel bracing at the peripheral face of the building. In this article, a set of critical parameters to identify the seismic design of buildings was associated in this data. The parameters were described in terms of dynamic properties as follows: (a) natural fundamental period, (b) mode shapes, (c) torsional irregularity, (d) stiffness and ductility, and (e) plastic hinges formation. Particularly, the estimated cost analysis of added materials plays an important role in choosing the suitable retrofitting technique for old buildings.
    Matched MeSH terms: Costs and Cost Analysis
  12. Development and Practical Application of a Multiple-Criteria Decision Analysis Framework on Respiratory Inhalers: Is It Always Useful in the MOH Malaysia Medicines Formulary Listing Context?
    Yong YV, Mahamad Dom SH, Ahmad Sa'ad N, Lajis R, Md Yusof FA, Abdul Rahaman JA
    MDM Policy Pract, 2021 03 30;6(1):2381468321994063.
    PMID: 33855190 DOI: 10.1177/2381468321994063
    Objectives. The current health technology assessment used to evaluate respiratory inhalers is associated with limitations that have necessitated the development of an explicit formulary decision-making framework to ensure balance between the accessibility, value, and affordability of medicines. This study aimed to develop a multiple-criteria decision analysis (MCDA) framework, apply the framework to potential and currently listed respiratory inhalers in the Ministry of Health Medicines Formulary (MOHMF), and analyze the impacts of applying the outputs, from the perspective of listing and delisting medicines in the formulary. Methods. The overall methodology of the framework development adhered to the recommendations of the ISPOR MCDA Emerging Good Practices Task Force. The MCDA framework was developed using Microsoft Excel 2010 and involved all relevant stakeholders. The framework was then applied to 27 medicines, based on data gathered from the highest levels of available published evidence, pharmaceutical companies, and professional opinions. The performance scores were analyzed using the additive model. The end values were then deliberated by an expert committee. Results. A total of eight main criteria and seven subcriteria were determined by the stakeholders. The economic criterion was weighted at 30%. Among the noneconomic criteria, "patient suitability" was weighted the highest. Based on the MCDA outputs, the expert committee recommended one potential medicine (out of three; 33%) be added to the MOHMF and one existing medicine (out of 24; 4%) be removed/delisted from the MOHMF. The other existing medicines remained unchanged. Conclusions. Although this framework was useful for deciding to add new medicines to the formulary, it appears to be less functional and impactful for the removal/delisting existing medicines from the MOHMF. The generalizability of this conclusion to other formulations remains to be confirmed.
    Matched MeSH terms: Costs and Cost Analysis
  13. Fulltext To travel is to live: embracing the emerging field of travel psychiatry
    Flaherty G, Chai SY, Hallahan B
    BJPsych Bull, 2020 Apr 13.
    PMID: 32279684 DOI: 10.1192/bjb.2020.32
    For a person with mental illness, travelling abroad can be challenging but it can be easier when the traveller and healthcare practitioner have a clear understanding of the likely impact of travel on the illness and of the illness on the travel experience. Travel may also precipitate first presentations of mental illness or unmask previously undiagnosed mental disorders. We propose that mental health problems should receive greater recognition in travel medicine and that psychiatrists should collaborate more closely with travel medicine clinicians to ensure that their patients benefit from the opportunities afforded by international travel.
    Matched MeSH terms: Costs and Cost Analysis
  14. Budget impact analysis of medicines: estimated values versus real-world evidence and the implications
    Faleiros DR, Alvares-Teodoro J, Nunes da Silva E, Godman BB, Gonçalves Pereira R, Gurgel Andrade EI, et al.
    Expert Rev Pharmacoecon Outcomes Res, 2021 May 27.
    PMID: 33971778 DOI: 10.1080/14737167.2021.1927716
    Objectives: Budget Impact Analyses (BIA) of medicines helps managers in promoting health systems' sustainability when assessing the role and value of new medicines. However, it is not clear whether BIAs typically underestimate or overestimate the impact on real-world budgets. This retroactive analysis seeks to compare estimated values obtained by a BIA and Real-World Evidence (RWE) to guide discussions.Methods: The estimated values were obtained through a BIA concerning the incorporation of adalimumab for the treatment of Rheumatoid Arthritis into the Brazilian Unified Health System (SUS) carried out retroactively and per international guidelines. RWE data was extracted from SUS computerized systems. We subsequently compared the number of treatments, costs, and Incremental Budget Impact (IBI).Results - The total number of treatments was underestimated by 10% (6,243) and the total expenditure was overestimated by 463% (US$ 4.7 billion). In five years, the total difference between the estimated values and real IBI reached US$ 1.1 billion. A current expenditure of US$ 1.0 was observed for every US$ 5.60 of estimated expenditure.Conclusion - The higher estimates from the BIA might cause decision makers to be more cautious with the introduction of a new medicine to reduce the opportunity costs for other interventions.
    Matched MeSH terms: Costs and Cost Analysis
  15. Fulltext Estimating direct medical costs of type 2 diabetes mellitus in the Philippines: a protocol
    Ng JYS, Clement IJ, Jimeno C, Sy RA, Mirasol R, De La Pena P, et al.
    BMJ Open, 2020 07 28;10(7):e025696.
    PMID: 32723733 DOI: 10.1136/bmjopen-2018-025696
    INTRODUCTION: Diabetes and its complications are a major cause of morbidity and mortality in the Philippines. The prevalence of diabetes in the Philippines has increased from 3.4 million in 2010 to 3.7 million in 2017. The government has formulated strategies to control this increase, for example, through its non-communicable disease prevention and control plan. However, there is scarce research on the financial burden of diabetes. Filling this gap may further help policymakers to make informed decisions while developing and implementing resource planning for relevant interventions. The primary objective of the current study is to estimate the direct medical costs associated with type 2 diabetes mellitus (T2DM).

    METHODS AND ANALYSIS: This is a 1-year retrospective cohort study of patients with T2DM in 2016. Data will be collected from: (1) hospital databases from public institutions to estimate the cost of diabetes treatment and (2) physician interviews to estimate the cost of management of diabetes in outpatient care. We will perform descriptive and comparative analyses on direct medical costs and healthcare resource utilisation, stratified by the presence of diabetes-associated complications.

    ETHICS AND DISSEMINATION: Research ethics board approval has been obtained from the Department of Health Single Joint Research Ethics Board and Cardinal Santos Medical Center Research Ethics Review Committee. Findings from the study will be reported in peer-reviewed scientific journals and local researcher meetings.

    Matched MeSH terms: Costs and Cost Analysis
  16. Fulltext Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries
    Chow CK, Nguyen TN, Marschner S, Diaz R, Rahman O, Avezum A, et al.
    BMJ Glob Health, 2020 11;5(11).
    PMID: 33148540 DOI: 10.1136/bmjgh-2020-002640
    OBJECTIVES: We aimed to examine the relationship between access to medicine for cardiovascular disease (CVD) and major adverse cardiovascular events (MACEs) among people at high risk of CVD in high-income countries (HICs), upper and lower middle-income countries (UMICs, LMICs) and low-income countries (LICs) participating in the Prospective Urban Rural Epidemiology (PURE) study.

    METHODS: We defined high CVD risk as the presence of any of the following: hypertension, coronary artery disease, stroke, smoker, diabetes or age >55 years. Availability and affordability of blood pressure lowering drugs, antiplatelets and statins were obtained from pharmacies. Participants were categorised: group 1-all three drug types were available and affordable, group 2-all three drugs were available but not affordable and group 3-all three drugs were not available. We used multivariable Cox proportional hazard models with nested clustering at country and community levels, adjusting for comorbidities, sociodemographic and economic factors.

    RESULTS: Of 163 466 participants, there were 93 200 with high CVD risk from 21 countries (mean age 54.7, 49% female). Of these, 44.9% were from group 1, 29.4% from group 2 and 25.7% from group 3. Compared with participants from group 1, the risk of MACEs was higher among participants in group 2 (HR 1.19, 95% CI 1.07 to 1.31), and among participants from group 3 (HR 1.25, 95% CI 1.08 to 1.50).

    CONCLUSION: Lower availability and affordability of essential CVD medicines were associated with higher risk of MACEs and mortality. Improving access to CVD medicines should be a key part of the strategy to lower CVD globally.

    Matched MeSH terms: Costs and Cost Analysis
  17. Fulltext Bilateral Proximal Femur Fractures in a Patient with Renal Tubular Acidosis: A Case Report
    Charl SS, Shahrul-Hisham S, Mohamad-Sha S
    Malays Orthop J, 2018 Mar;12(1):42-44.
    PMID: 29725512 MyJurnal DOI: 10.5704/MOJ.1803.009
    The diagnosis of pathological fractures is on the rise. The morbidity involved does not only burden the patient and their families but it has a great toll on the healthcare system as well. Early identification of the patient at risk is an invaluable tool to cut cost and improve the patient's quality of life. Multiple renal pathologies have been highlighted in relation to the risk of pathological fractures; however, complications in renal tubular acidosis have been rarely documented. Nevertheless, prompt action with adequate and relevant patient education ultimately can reduce the associated morbidity. We present a case of poor control of the disease and its debilitating pathological fracture complications.
    Matched MeSH terms: Costs and Cost Analysis
  18. Fulltext Cost implication analysis of concrete and Masonry waste in construction project
    Kasvar, K.K., Nagapan, S., Abdullah, A.H., Ullah, K., Deraman, R., Yunus, R., et al.
    Pertanika Journal of Science & Technology, 2017;25(105):177-184.
    MyJurnal
    Concrete and masonry waste are the main types of waste typically generated at a construction project. There is a lack of studies in the country regarding the cost implication of managing these types of construction waste To address this need in Malaysia, the study is carried out to measure the disposal cost of concrete and masonry waste. The study was carried out by a site visit method using an indirect measurement approach to quantify the quantity of waste generated at the project. Based on the recorded number of trips for waste collection, the total expenditure to dispose the waste were derived in three construction stages. Data was collected four times a week for the period July 2014 to July 2015. The total waste generated at the study site was 762.51 m3 and the cost incurred for the 187 truck trips required to dispose the waste generated from the project site to the nearby landfill was RM22,440.00. The findings will be useful to both researchers and policy makers concerned with construction waste.
    Matched MeSH terms: Costs and Cost Analysis
  19. Fulltext Field evaluation of magnetic actuator driven switchgear in Malaysia
    Mohd Dzaki, Mohd Amir, Sanuri, Ishak
    Pertanika Journal of Science & Technology, 2017;25(102):61-68.
    MyJurnal
    Magnetic actuator driven switchgear is a new medium voltage switchgear technology. In this switchgear, the conventional spring mechanism which is used to operate the circuit breaker is replaced with a magnetic actuator mechanism. The suitability of this technology in the Malaysian utility network specifically in highly loaded areas with frequent switching was assessed via a field evaluation. Preliminary results indicated that magnetic actuator driven switchgear perform commendably on the safety aspect, on-site performance monitoring and online diagnostic test results. However, there are several concerns that need to be addressed such as the ease of installation, substation system requirements, high life cycle cost and reliability of components, before this technology can be used widely.
    Matched MeSH terms: Costs and Cost Analysis
  20. Fulltext Occupational accident cost estimation: a case study in wood based related industries
    Jafri Mohd Rohani, Hood Atan, Wan Harun Wan Hamid, Mohamed Fitri Johari, Edly Ramly
    Journal of Occupational Safety and Health, 2015;12(1):109-116.
    MyJurnal
    This objective of the study is to estimate occupational accident cost in manufacturing industries, especially in
    wood based related industries. The study attempts to identify, define, and classify the cost components of occupational
    accident related cost and to catalogue the various economic approaches used to estimate the entire costs of occupational
    accident and to propose the risk prevention plan. The study uses local specific approach by reviewing company
    historical records on occupational accident as reported in JKKP 6, JKKP 8, JKKP 9 and company internal investigation
    reports. For each occupational accident, the site safety officer in charge, human resource and, account employee,
    supervisor, victim, related co-workers and relatives were interviewed in order to estimate direct costs, indirect costs,
    prevention costs and other personal cost related to the accident. Other related information such as personal data of the
    victim, type of injuries, location of injuries and cause of injuries were recorded. A total of 24 occupational accidents
    data for the past five years were analyzed in the cost of accident summary report to determine the overall ratio of direct
    to indirect cost and ratio of total cost of accident to prevention cost. A further analysis was carried out to determine
    the most significant cost of accident related to demographic profiles for Malaysian and Non Malaysian employees. In
    conclusion, this study has determined the ratio of direct to indirect cost of occupational accident and has proposed the
    risk prevention plan with additional information on cost of accident and cost of prevention.
    Matched MeSH terms: Costs and Cost Analysis
Related Terms
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links